title: Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.
abstract: Recently, important changes have been reported regarding the epidemiology of bacterial infections in liver cirrhosis. There is an emergence of multiresistant bacteria in many European countries and also worldwide, including the United States and South Korea. The classic empirical antibiotic treatment (third-generation cephalosporins, e.g., ceftriaxone, cefotaxime or amoxicillin-clavulanic acid) is still effective in infections acquired in the community, but its failure rate in hospital acquired infections and in some health-care associated infections is high enough to ban its use in these settings. The current editorial focuses on the different epidemiology of bacterial infections in cirrhosis across countries and on its therapeutic implications.
authors.affiliation: Juan Acevedo, Department of Gastroenterology and Hepatology, Queen Alexandra Hospital, PO6 3LY Portsmouth, United Kingdom.
authors.forename: Juan
authors.initials: J
authors.lastname: Acevedo
keywords: Antibiotic; Bacterial infections; Liver cirrhosis; Multiresistant bacteria